FIELD: chemistry.
SUBSTANCE: invention relates to an amorphous form of the compound represented by the formula (I) wherein the powder X-ray diffractogram of the amorphous form does not have any sharp diffraction peak and has a wide reclined diffraction peak at an angle of 2θ between 10° and 25°, as well as to a method of production thereof.
EFFECT: new amorphous form of the compound represented by the formula (I) is produced which can be used as a PPAR agonist, wherein the amorphous form is characterized by significant stability.
7 cl, 3 dwg, 5 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRROLIDINE DERIVATIVES AS PPAR AGONISTS | 2017 |
|
RU2711991C1 |
| C-ANILINOQUINAZOLINE COMPOUNDS AND THEIR USE IN CANCER TREATMENT | 2018 |
|
RU2769694C2 |
| SOLID FORMS (2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZIL)PHENYL)-6-(METHYLTHIO)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL AND METHODS FOR THEIR OBTAINING | 2009 |
|
RU2505543C2 |
| CRYSTALLINE OR AMORPHOUS FORM OF FXR AGONISTS BEING STEROID DERIVATIVES, THEIR PRODUCTION METHOD AND THEIR USE | 2018 |
|
RU2800751C2 |
| 3,7-DIAZABICYCLO[3,3,1]-CONTAINING PREPARATIONS AS ANTI-ARRHYTHMIC COMPOUNDS | 2002 |
|
RU2286993C2 |
| CRYSTALLINE FORM OF A TRICYCLIC COMPOUND AND APPLICATION THEREOF | 2019 |
|
RU2775753C1 |
| THIENODIAZEPINE DERIVATIVES AND THEIR USE | 2018 |
|
RU2795005C2 |
| 2,3-DIHYDRO-1H-PYRROLISINE-7-FORMAMIDE DERIVATIVE AND ITS APPLICATIONS | 2019 |
|
RU2792726C2 |
| MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR | 2011 |
|
RU2576036C2 |
| SUBSTITUTED INDOLE COMPOUNDS AS REDUCING REGULATORS OF ESTROGEN RECEPTORS | 2017 |
|
RU2722441C2 |
